vs
NOODLES & Co（NDLS）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是NOODLES & Co的1.7倍（$207.3M vs $122.1M），NOODLES & Co净利率更高（-7.5% vs -62.0%，领先54.5%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs -4.1%），NOODLES & Co自由现金流更多（$-2.8M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs -1.2%）
Noodles & Company是源自美国的休闲快餐连锁品牌，主打融合多国风味及美式特色的面条菜品，同时也供应汤品和沙拉。品牌由亚伦·肯尼迪创立于1995年，总部位于科罗拉多州布鲁姆菲尔德，截至2022年年中，品牌已在美国31个州开出了458家门店。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
NDLS vs RARE — 直观对比
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $122.1M | $207.3M |
| 净利润 | $-9.2M | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | -5.2% | -54.7% |
| 净利率 | -7.5% | -62.0% |
| 营收同比 | -4.1% | 25.9% |
| 净利润同比 | 32.8% | 3.5% |
| 每股收益（稀释后） | $-0.20 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | — | $207.3M | ||
| Q3 25 | $122.1M | $159.9M | ||
| Q2 25 | $123.8M | $166.5M | ||
| Q1 25 | — | $139.3M | ||
| Q4 24 | $122.8M | $164.6M | ||
| Q3 24 | $127.4M | $139.5M | ||
| Q2 24 | $121.4M | $147.0M | ||
| Q1 24 | $124.3M | $108.8M |
| Q4 25 | — | $-128.6M | ||
| Q3 25 | $-9.2M | $-180.4M | ||
| Q2 25 | $-9.1M | $-115.0M | ||
| Q1 25 | — | $-151.1M | ||
| Q4 24 | $-6.8M | $-133.2M | ||
| Q3 24 | $-13.6M | $-133.5M | ||
| Q2 24 | $-6.1M | $-131.6M | ||
| Q1 24 | $-6.1M | $-170.7M |
| Q4 25 | — | -54.7% | ||
| Q3 25 | -5.2% | -106.9% | ||
| Q2 25 | -5.2% | -64.8% | ||
| Q1 25 | — | -102.6% | ||
| Q4 24 | -3.9% | -74.3% | ||
| Q3 24 | -9.0% | -94.6% | ||
| Q2 24 | -3.4% | -79.1% | ||
| Q1 24 | -3.7% | -151.9% |
| Q4 25 | — | -62.0% | ||
| Q3 25 | -7.5% | -112.8% | ||
| Q2 25 | -7.3% | -69.0% | ||
| Q1 25 | — | -108.5% | ||
| Q4 24 | -5.5% | -80.9% | ||
| Q3 24 | -10.7% | -95.7% | ||
| Q2 24 | -5.1% | -89.5% | ||
| Q1 24 | -4.9% | -156.8% |
| Q4 25 | — | $-1.28 | ||
| Q3 25 | $-0.20 | $-1.81 | ||
| Q2 25 | $-0.20 | $-1.17 | ||
| Q1 25 | — | $-1.57 | ||
| Q4 24 | $-0.15 | $-1.34 | ||
| Q3 24 | $-0.30 | $-1.40 | ||
| Q2 24 | $-0.14 | $-1.52 | ||
| Q1 24 | $-1.64 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.7M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-38.9M | $-80.0M |
| 总资产 | $280.6M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | — | $421.0M | ||
| Q3 25 | $4.7M | $202.5M | ||
| Q2 25 | $1.4M | $176.3M | ||
| Q1 25 | — | $127.1M | ||
| Q4 24 | $3.3M | $174.0M | ||
| Q3 24 | $1.8M | $150.6M | ||
| Q2 24 | $1.3M | $480.7M | ||
| Q1 24 | $3.0M | $112.3M |
| Q4 25 | — | $-80.0M | ||
| Q3 25 | $-38.9M | $9.2M | ||
| Q2 25 | $-13.9M | $151.3M | ||
| Q1 25 | — | $144.2M | ||
| Q4 24 | $3.7M | $255.0M | ||
| Q3 24 | $9.6M | $346.8M | ||
| Q2 24 | $21.9M | $432.4M | ||
| Q1 24 | $27.2M | $140.3M |
| Q4 25 | — | $1.5B | ||
| Q3 25 | $280.6M | $1.2B | ||
| Q2 25 | $319.4M | $1.3B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | $340.5M | $1.5B | ||
| Q3 24 | $346.3M | $1.5B | ||
| Q2 24 | $360.4M | $1.6B | ||
| Q1 24 | $368.1M | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.3M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $-2.8M | $-100.8M |
| 自由现金流率自由现金流/营收 | -2.3% | -48.6% |
| 资本支出强度资本支出/营收 | 5.8% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-7.5M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | — | $-99.8M | ||
| Q3 25 | $4.3M | $-91.4M | ||
| Q2 25 | $4.0M | $-108.3M | ||
| Q1 25 | — | $-166.5M | ||
| Q4 24 | $5.8M | $-79.3M | ||
| Q3 24 | $4.7M | $-67.0M | ||
| Q2 24 | $7.0M | $-77.0M | ||
| Q1 24 | $164.0K | $-190.7M |
| Q4 25 | — | $-100.8M | ||
| Q3 25 | $-2.8M | $-92.7M | ||
| Q2 25 | $1.1M | $-110.7M | ||
| Q1 25 | — | $-167.8M | ||
| Q4 24 | $-1.3M | $-79.5M | ||
| Q3 24 | $-4.5M | $-68.6M | ||
| Q2 24 | $-1.6M | $-79.0M | ||
| Q1 24 | $-15.2M | $-193.9M |
| Q4 25 | — | -48.6% | ||
| Q3 25 | -2.3% | -58.0% | ||
| Q2 25 | 0.9% | -66.5% | ||
| Q1 25 | — | -120.5% | ||
| Q4 24 | -1.1% | -48.3% | ||
| Q3 24 | -3.5% | -49.2% | ||
| Q2 24 | -1.4% | -53.7% | ||
| Q1 24 | -12.2% | -178.2% |
| Q4 25 | — | 0.5% | ||
| Q3 25 | 5.8% | 0.8% | ||
| Q2 25 | 2.4% | 1.5% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | 5.8% | 0.1% | ||
| Q3 24 | 7.2% | 1.2% | ||
| Q2 24 | 7.1% | 1.4% | ||
| Q1 24 | 12.3% | 3.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NDLS
| Food And Beverage | $119.6M | 98% |
| Franchise | $2.5M | 2% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
